Anthony E Lang Selected Research

Myoclonic dystonia

11/2018	ADCK3-related Coenzyme Q10 Deficiency: A Potentially Treatable Genetic Disease.
1/2018	Myoclonus-dystonia: classification, phenomenology, pathogenesis, and treatment.
8/2014	Bilateral pallidal stimulation for sargoglycan epsilon negative myoclonus.
3/2008	Phenotypic spectrum and sex effects in eleven myoclonus-dystonia families with epsilon-sarcoglycan mutations.
12/2004	Involvement of human thalamus in the preparation of self-paced movement.
2/2003	Acute effect of transcutaneous electrical nerve stimulation on tremor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anthony E Lang Research Topics

Disease

171	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2002
36	Dyskinesias (Dyskinesia) 11/2021 - 09/2003
30	Parkinsonian Disorders (Parkinsonism) 01/2021 - 08/2002
19	Movement Disorders (Movement Disorder) 10/2020 - 01/2003
16	Tremor (Tremors) 10/2020 - 02/2003
15	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 03/2006
13	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2021 - 03/2003
10	Dystonia (Limb Dystonia) 12/2019 - 04/2003
9	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 11/2021 - 05/2010
8	Cognitive Dysfunction 01/2021 - 02/2014
8	Dementia (Dementias) 01/2019 - 09/2004
7	Psychotic Disorders (Schizoaffective Disorder) 01/2020 - 03/2004
7	Hallucinations (Hallucination) 01/2016 - 03/2002
7	Gambling (Pathological Gambling) 12/2012 - 11/2006
6	Tauopathies 01/2022 - 03/2006
6	Multiple System Atrophy 01/2022 - 11/2007
6	Synucleinopathies 01/2020 - 03/2006
6	Myoclonic dystonia 11/2018 - 02/2003
6	Disease Progression 09/2017 - 10/2007
6	Hypokinesia (Bradykinesia) 11/2015 - 11/2003
6	Sleepiness 08/2012 - 01/2002
5	Inflammation (Inflammations) 01/2022 - 01/2018
5	Myoclonus (Nocturnal Myoclonus) 01/2021 - 10/2009
5	Neuroinflammatory Diseases 01/2020 - 01/2015
4	Chorea (Rheumatic Chorea) 05/2022 - 08/2004
4	Corticobasal Degeneration 01/2020 - 01/2014
4	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2014
4	DiGeorge Syndrome (Syndrome, DiGeorge) 01/2018 - 11/2013
4	Dizziness (Lightheadedness) 08/2016 - 04/2010
3	Ataxia (Dyssynergia) 10/2020 - 10/2009
3	Prodromal Symptoms 01/2020 - 05/2013
3	Dopa-responsive Dystonia 01/2020 - 07/2014
3	Tardive Dyskinesia 12/2019 - 08/2004
3	Orthostatic Hypotension (Postural Hypotension) 01/2019 - 08/2016
3	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2016 - 12/2012
3	Atrophy 11/2015 - 03/2013
3	Disorders of Excessive Somnolence (Hypersomnia) 08/2012 - 03/2002
2	Conversion Disorder (Astasia Abasia) 02/2020 - 02/2007
2	Brain Diseases (Brain Disorder) 01/2019 - 06/2007
2	Proteostasis Deficiencies 01/2019 - 01/2014
2	Seizures (Absence Seizure) 01/2017 - 06/2015

Drug/Important Bio-Agent (IBA)

55	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 03/2002
26	Biomarkers (Surrogate Marker)IBA 11/2021 - 05/2003
22	Dopamine Agonists (Dopamine Agonist)IBA 11/2021 - 01/2002
19	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 06/2002
16	SynucleinsIBA 01/2022 - 03/2006
15	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2003
14	Pharmaceutical PreparationsIBA 09/2021 - 03/2002
9	Phosphotransferases (Kinase)IBA 12/2019 - 12/2004
8	Leucine (L-Leucine)FDA Link 12/2019 - 01/2008
6	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 11/2021 - 10/2004
5	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2020 - 02/2006
5	Amantadine (Aman)FDA LinkGeneric 01/2020 - 12/2010
5	Amyloid (Amyloid Fibrils)IBA 01/2020 - 01/2017
5	Carbidopa (Lodosyn)FDA LinkGeneric 01/2019 - 07/2010
5	Antipsychotic Agents (Antipsychotics)IBA 11/2018 - 02/2007
5	Dopamine Agents (Dopaminergic Agents)IBA 01/2016 - 03/2002
5	Pramipexole (Mirapex)FDA LinkGeneric 04/2014 - 01/2002
5	Dihydroxyphenylalanine (Dopa)IBA 06/2013 - 03/2002
5	ropinirole (Requip)FDA LinkGeneric 12/2007 - 01/2002
4	alpha-SynucleinIBA 01/2022 - 05/2013
4	EnzymesIBA 01/2020 - 12/2004
4	Cholinergic Antagonists (Anticholinergics)IBA 01/2020 - 04/2014
4	Clozapine (Clozaril)FDA LinkGeneric 01/2020 - 04/2014
4	Biological ProductsIBA 12/2019 - 01/2017
4	Caffeine (No Doz)FDA LinkGeneric 10/2017 - 11/2011
4	Antidepressive Agents (Antidepressants)IBA 04/2014 - 03/2004
4	Selegiline (E250)FDA LinkGeneric 03/2011 - 04/2008
4	Tocopherols (Tocopherol)IBA 03/2011 - 04/2008
3	Coffee FDA Link 01/2022 - 12/2004
3	Botulinum Toxins (Botulinum Toxin)IBA 11/2021 - 05/2003
3	Protein AggregatesIBA 01/2020 - 02/2013
3	Dopamine Receptors (Dopamine Receptor)IBA 12/2019 - 01/2014
3	CalciumIBA 03/2017 - 02/2013
3	Uric Acid (Urate)IBA 11/2015 - 06/2008
3	salicylhydroxamic acid (SHAM)IBA 08/2015 - 11/2009
3	3,9-bis((ethylthio)methyl)-K-252aIBA 03/2011 - 12/2009
3	fluorodopa F 18IBA 03/2006 - 07/2003
2	Apolipoproteins E (ApoE)IBA 01/2021 - 12/2012
2	Isradipine (Dynacirc)FDA LinkGeneric 11/2020 - 01/2017
2	Dopamine AntagonistsIBA 11/2020 - 06/2013
2	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2020 - 01/2020
2	Protons (Proton)IBA 01/2020 - 01/2017
2	Quetiapine Fumarate (Seroquel)FDA Link 01/2020 - 10/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2017
2	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2020 - 01/2014
2	Adenylyl Cyclases (Adenylyl Cyclase)IBA 09/2019 - 01/2017
2	hydroxide ionIBA 01/2019 - 12/2016
2	tau Proteins (tau Protein)IBA 01/2018 - 01/2017
2	IronIBA 09/2017 - 03/2013
2	rasagiline (Azilect)FDA Link 07/2017 - 01/2016

Therapy/Procedure

49	Deep Brain Stimulation 01/2022 - 01/2002
47	Therapeutics 11/2021 - 11/2003
6	Pallidotomy 12/2019 - 04/2003
5	Activities of Daily Living (ADL) 01/2019 - 10/2004
4	Electrodes (Electrode) 08/2010 - 11/2002
3	Transcranial Magnetic Stimulation 01/2021 - 11/2003
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2020
2	Precision Medicine 12/2019 - 02/2017
2	Appendectomy 01/2019 - 01/2016